Kedrion Biopharma’s subsidiary, Plasmaferezis Állomás Kft (PFA), has been awarded International Quality Plasma Program (IQPP) certification by the Plasma Protein Therapeutics Association (PPTA) for its plasma collection centers in Hungary. The three centers – two in Budapest and one in Debrecen – are the first in the country to become IQPP certified.
Certification is conferred after a rigorous inspection by an independent third party, and demonstrated compliance with voluntary standards that ensure the highest level of quality and safety of human source plasma.
PPTA Vice President Joshua Penrod Source stated, “We congratulate Plazmaferezis Állomás Kft on obtaining this mark of distinction which demonstrates its commitment to plasma quality and safety.”
Gabriella Komlodi, Managing Director of Plazmaferezis Állomás, observed, “Considering that the plasma collected ultimately serves the health and well-being of Hungarian patients, as part of Kedrion Group, we set the bar high and therefore wanted to measure up to the IQPP standards. Whatever we do, we want to do it right.”
People worldwide depend on lifesaving plasma protein therapies to treat bleeding and immune disorders as well as other diseases and injury. PFA shares the Kedrion mission to continuously improve on its dedication to safety and quality from donor to patient.
